Scopolamine Transdermal System Patch, Extended Release
Product Images NDC 71335-2718

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Scopolamine Transdermal System (NDC 71335-2718). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Extended Label (713352718 E Label)

Extended Label (713352718 E Label)
This text describes a transdermal system intended for motion sickness and post-operative nausea & vomiting prevention, delivering approximately 1mg over three days. The product contains inactive components such as crospovidone, isopropyl palmitate, and light mineral oil. The application instructions include washing hands thoroughly before use, applying to a hairless area behind the ear, and avoiding cutting the system. It also warns about potential side effects like drowsiness, blurred vision, and advises removal before undergoing an MRI procedure to prevent possible burns.*
FDA Label Image

Cross-section (Cross Section)

Cross-section (Cross Section)
FDA Label Image

Figure 4 (Figure 4)

Figure 4 (Figure 4)
This is a description of a tan-colored transdermal system with a metallic adhesive surface and a clear disposable release liner. The system seems to be imprinted and offers a graphical representation in Figure 4.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
This is a clear, disposable release liner with a metallic adhesive surface and a tan backing membrane. It has an imprint "SCOP 1mg/3 days". See Figure 1 for reference.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
This instruction indicates to cut open the package along the dashed line as shown in Figure 2.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
This is a description of a tan-colored transdermal system displayed in Figure 5.*
FDA Label Image

Label (Lbl713352718)

Label (Lbl713352718)
Each transdermal system contains 1.3 mg of scopolamine formulated to deliver approximately 1 mg over 3 days. It is recommended to use only one transdermal system at a time. Store the system upright at 20°C to 25°C (68°F to 77°F) and keep it out of reach of children. The dosage and administration details can be obtained by scanning the package insert's QR code. This medication may cause drowsiness and blurred vision. Ensure the foil seal is intact before use. If the seal is broken, do not use the system.*
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.